![Scott Rottinghaus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 317 081 $ per 2026-08-31
Scott T.
Rottinghaus is currently Chief Medical Officer at Enanta Pharmaceuticals, Inc. since 2022.
Formerly, Dr. Rottinghaus was Vice President & Head-Clinical Development at Alexion Pharmaceuticals, Inc. and Assistant Clinical Professor at Yale School of Medicine from 2017 to 2019.
Education includes graduate studies at the University of Cambridge, undergraduate studies at Kansas State University, and a doctorate from Mayo Medical School.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-08 | 23 787 ( 0,08 % ) | 317 081 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-08-08 |
| Företag | Position | Slut |
|---|---|---|
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2019-01-01 |
| ALEXION PHARMACEUTICALS, INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kansas State University
 Kansas State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mayo Medical School
 Mayo Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
